IP Library › Assignment 060131/0148
Patent Assignment
Reel/Frame 060131/0148

Correction of an Error in Assignor's Name in a Cover Sheet Previously Recorded at Reel 059925 Frame 0772.

Recorded: 2022-05-20 Pages: 31
Assignor
PLEXXIKON INC.
Executed: 2022-03-10
Assignee
OPNA IMMUNO-ONCOLOGY SA
ROUTE DE LA CORNICHE 6, EPALINGES, 1066, SWITZERLAND
Covered Properties (23)
Compounds and Methods for CD73 Modulation and Indications Therefor
Combinational Drug Therapies
Compounds and Methods for Kinase Modulation, and Indications Therefor
Patent: 8,901,118 →
Application: 13/090,969 →
Publication: US 2011/0263595
Heterocyclic Compounds and Uses Thereof
Patent: 9,718,847 →
Application: 14/486,986 →
Publication: US 2015/0133400
Compounds and Methods for Kinase Modulation, and Indications Therefor
Patent: 9,682,981 →
Application: 14/556,709 →
Publication: US 2015/0183793
Heterocyclic Compounds and Uses Thereof
Patent: 9,822,109 →
Application: 14/846,545 →
Publication: US 2016/0068528
Heterocyclic Compounds and Uses Thereof
Patent: 9,771,363 →
Application: 15/269,054 →
Publication: US 2017/0081326
Heterocyclic Compounds and Uses Thereof
Application: 15/654,538 →
Publication: US 2017/0320899
Heterocyclic Compounds and Uses Thereof
Patent: 9,975,894 →
Application: 15/689,931 →
Publication: US 2017/0362231
Heterocyclic Compounds and Uses Thereof
Application: 15/814,179 →
Publication: US 2018/0072722
Crystalline Forms of a Compound That Inhibits Bromodomain
Application: 15/925,270 →
Publication: US 2018/0265508
Heterocyclic Compounds and Uses Thereof
Application: 15/977,772 →
Publication: US 2018/0327403
Solid Forms of a Compound for Modulating Kinases
Application: 16/158,107 →
Publication: US 2019/0161484
Heterocyclic Compounds and Uses Thereof
Application: 16/441,610 →
Publication: US 2019/0367507
Heterocyclic Compounds and Uses Thereof
Application: 16/838,383 →
Publication: US 2020/0339571
COMPOUNDS AND METHODS FOR EP300 or CBP MODULATION AND INDICATIONS THEREFOR
Application: 16/843,700 →
Publication: US 2021/0315872
Compounds and Methods for CD73 Modulation and Indications Therefor
Application: 17/238,121 →
Publication: US 2022/0144805
Solid Forms of a Compound for Modulating Kinases
Application: 17/368,582 →
Publication: US 2022/0081436
Heterocyclic Compounds and Uses Thereof
Application: 17/387,775 →
Combinational Drug Therapies
Application: 17/407,811 →
Publication: US 2022/0054507
Compounds and Methods for Yap/Tead Modulation and Indications Therefor
Application: 63/187,226 →
Compounds and Methods for Yap/Tead Modulation and Indications Therefor
Application: 63/304,504 →
Compounds and Methods for Yap/Tead Modulation and Indications Therefor
Application: 63/309,442 →
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 19, 2013
From: ZHANG, JIAZHONG; IBRAHIM, PRABHA N.; SPEVAK, WAYNE; TSAI, JAMES
To: PLEXXIKON INC.
Reel/Frame 031631/0339 →
Assignment of Assignor's Interest Nov 7, 2014
From: ZHANG, JIAZHONG; BUELL, JOHN; CHAN, KATRINA; IBRAHIM, PRABHA N.
To: PLEXXIKON INC.
Reel/Frame 034125/0597 →
Assignment of Assignor's Interest Feb 17, 2016
From: ZHANG, JIAZHONG; IBRAHIM, PRABHA N.; SPEVAK, WAYNE; TSAI, JAMES
To: PLEXXIKON INC.
Reel/Frame 037757/0474 →
Assignment of Assignor's Interest Dec 23, 2016
From: ZHANG, JIAZHONG; BUELL, JOHN; CHAN, KATRINA; IBRAHIM, PRABHA N.
To: PLEXXIKON INC.
Reel/Frame 040760/0032 →
Assignment of Assignor's Interest Jan 4, 2017
From: ZHANG, JIAZHONG; SPEVAK, WAYNE
To: PLEXXIKON INC.
Reel/Frame 040839/0759 →
Assignment of Assignor's Interest Aug 1, 2017
From: IBRAHIM, PRABHA N.; SPEVAK, WAYNE; ZHANG, JIAZHONG; SHI, SONGYUAN
To: PLEXXIKON INC.
Reel/Frame 043154/0912 →
Assignment of Assignor's Interest Sep 14, 2017
From: IBRAHIM, PRABHA N.; SPEVAK, WAYNE; ZHANG, JIAZHONG; SHI, SONGYUAN
To: PLEXXIKON INC.
Reel/Frame 043590/0924 →
Assignment of Assignor's Interest Apr 4, 2018
From: ZHANG, JIAZHONG; BUELL, JOHN; CHAN, KATRINA; IBRAHIM, PRABHA N.
To: PLEXXIKON INC.
Reel/Frame 045436/0745 →
Assignment of Assignor's Interest Apr 30, 2018
From: ZHANG, JIAZHONG; SPEVAK, WAYNE
To: PLEXXIKON INC.
Reel/Frame 045674/0109 →
Assignment of Assignor's Interest May 22, 2018
From: LIN, JACK; NESPI, MARIKA; WALTERS, JASON
To: PLEXXIKON INC.
Reel/Frame 045876/0081 →
Assignment of Assignor's Interest Aug 9, 2018
From: IBRAHIM, PRABHA N.; SPEVAK, WAYNE; ZHANG, JIAZHONG; SHI, SONGYUAN
To: PLEXXIKON INC.
Reel/Frame 046602/0008 →
Assignment of Assignor's Interest Aug 30, 2019
From: IBRAHIM, PRABHA N.; SPEVAK, WAYNE; ZHANG, JIAZHONG; SHI, SONGYUAN
To: PLEXXIKON INC.
Reel/Frame 050226/0784 →
Employment Agreement May 28, 2020
From: PATEL, RASHMIN
To: PLEXXIKON INC.
Reel/Frame 052786/0683 →
Assignment of Assignor's Interest May 28, 2020
From: IBRAHIM, PRABHA N.; REZAEI, HAMID; NESPI, MARIKA; POWELL, BEN
To: PLEXXIKON INC.
Reel/Frame 052781/0182 →
Assignment of Assignor's Interest Jun 25, 2020
From: IBRAHIM, PRABHA N.; SPEVAK, WAYNE; ZHANG, JIAZHONG; SHI, SONGYUAN
To: PLEXXIKON INC.
Reel/Frame 053040/0891 →
Assignment of Assignor's Interest Jul 12, 2021
From: SHI, SONGYUAN; BUELL, JOHN; GUO, ZUOJUN; LY, CUONG
To: PLEXXIKON INC.
Reel/Frame 056830/0255 →
Assignment of Assignor's Interest Aug 12, 2021
From: SPEVAK, WAYNE; BUELL, JOHN; GUO, ZUOJUN; INAGAKI, HIROAKI
To: PLEXXIKON INC.
Reel/Frame 057167/0026 →
Assignment of Assignor's Interest May 10, 2022
From: PLEXXICON INC.
To: OPNA IMMUNO-ONCOLOGY SA
Reel/Frame 059925/0772 →
Change of Name Mar 2, 2023
From: OPNA IMMUNO-ONCOLOGY SA
To: OPNA BIO SA
Reel/Frame 062856/0846 →
Corrective Assignment to Correct the 16TH Patent Number Previously Recorded at Reel: 062856 Frame: 0846. Assignor(S) Hereby Confirms the Change of Name. Mar 28, 2023
From: OPNA IMMUNO-ONCOLOGY SA
To: OPNA BIO SA
Reel/Frame 063588/0355 →